Other established pancreatic cell lines were considered for these assays, however, our assessment required functional TGFβ signaling, which limited our pancreatic cancer cell line choice to those cell lines without mutations in the TGFβ signaling pathway. This evidence concerns the gene TGFB1 and familial pancreatic carcinoma.